October 28, 2024 VIA EMAIL DELIVERY: Professor Benjamin Sredni Professor Michael Albeck Adv. Avichai Isachar Adv. Hananel Levy Re: License term Sheet Agreement effective July 17, 2023 ( the “Agreement”) Gentlemen: Pursuant to Paragraph 12 of the above...License Term Sheet Agreement • November 8th, 2024 • Qrons Inc. • Biological products, (no disgnostic substances)
October 28, 2024 VIA EMAIL DELIVERY: Mr. Adiv Baruch, Chairman Mr. Danny Hardon, CEO Ariel Scientific Innovations Ltd. Ariel University Ariel 40070 Israel Re: Royalty and License Fee Sharing Agreement dated as of November 30, 2019 ( the “Agreement”)...Royalty and License Fee Sharing Agreement • November 8th, 2024 • Qrons Inc. • Biological products, (no disgnostic substances)
An Exit Event as defined by the above caption Agreement has occurred whereby Qrons has agreed to enter into a merger agreement. Pursuant to Paragraph 2, Qrons is issuing to Ariel University 3% of its issued and outstanding shares. Qrons currently has 13,949,789 such shares and will issue to Ariel 418,494 shares to be deposited into Ariel’s account at the Company’s Transfer Agent.
